In the past 52-week period, shares of Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) have moved within the range of $1.01 to $3.24. On the stock’s most recent trading day, the company’s shares ended the regular session at $2.96, which is 8.64% higher than its 52-week high.
Catalyst Pharmaceuticals, Inc. (CPRX) has demonstrated a 20-day simple moving average (SMA) of 4.48%, and a 50-day SMA of 11.07%. This public company’s current market capitalization stands at $260.72 million.Analyzing Consensus Estimates, Sales Revenue and Net Income
Gauging the level of enthusiasm that Wall Street analysts have for a particular stock is important when considering an investment. According to the latest data, the consensus recommendation for Catalyst Pharmaceuticals, Inc. (CPRX) is Outperform.
When it comes to reporting sales figures, public companies typically post earnings and revenue that fall above or below the average Wall Street forecast. In the most recent quarterly financial report, for the quarter ending Sep. 2017, Catalyst Pharmaceuticals, Inc. (CPRX) delivered a 0.00% surprise with its net revenue.
Meanwhile, during the same quarter Catalyst Pharmaceuticals, Inc. (CPRX) delivered a -9.09% earnings surprise. Net earnings for the quarter were posted at -$0.05 per share, whereas Wall Street had forecast -$0.05 per share.Ownership at Catalyst Pharmaceuticals, Inc. (CPRX), According to Most Recent SEC Filings
A publicly-traded company’s most recent 13F filings give us important details about the organization’s institutional ownership. Catalyst Pharmaceuticals, Inc. (CPRX) has 0 billion shares outstanding currently, 39.62% of which belong to institutional investors. Those institutional holdings amount to $0.1 billion.
Additionally, according to the most recent 13F filing from Catalyst Pharmaceuticals, Inc. (CPRX), there were 14 new positions totaling 1,021,355 shares of the company’s stock. There were 5 sold out positions, on the other hand, totaling 909,898 shares.Short, Medium and Long Term Indicators
Taking a look at a stock’s average volume – in the long, medium and short terms – is helpful for understanding investor sentiment and trading activity. Catalyst Pharmaceuticals, Inc. (CPRX) has had a 20-day average volume of 971,695 shares, with an average of 20% of short term indicators pointed at Buy.
The stock’s 50-day average volume has been 671,856 shares, with an average of 25% of medium term indicators pointing toward Buy. Finally, its 100-day average volume is 762,020 shares with 33% of long-term indicators pointing to Buy.